hotspot -WSS

hotspot

author：explore 2025-09-30 00:48:33 - browse：168

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： How a symptom of dementia informs our understanding of creativity

WSS

Male doctors called my cancer incurable. A female doctor showed it wasn't

AstraZeneca challenges Medicare drug negotiation program

Departing Stanford president retracts two papers

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Departing Stanford president retracts two papers

How Long Island became the ‘eugenics capital of the world’

knowledge

hotspot

hotspot

New air purifier tech could be key to improving indoor air quality

Psilocybin's anti

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Male doctors called my cancer incurable. A female doctor showed it wasn't

Drug repurposing or repositioning? The language matters

AstraZeneca bets AAV gene therapy will still deliver the goods

After affirmative action ruling, medical educators look to 'holistic review'

AstraZeneca bets AAV gene therapy will still deliver the goods

What does generative AI mean for health care? We asked experts

Study suggests new cause of Down syndrome: cells linked to aging

leisure time

Feds fine Medicare Advantage plans for overcharging members

Study suggests new cause of Down syndrome: cells linked to aging

Appeals court upholds limits to abortion pill

In science, is the line between industry and academia shifting?

A preacher's new calling: Diversifying neuroscience research

Study finds new variant for Parkinson’s in African populations

focus

explore

focus

Wikipedia